Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
ELTX on Nasdaq
Jay Venkatesan - trading volume in the past year for Elicio Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Pre-Funded Warrants |
50K |
$250K |
$4.99 |
Jun 28, 2024 |
Direct |
Common Stock |
|
Pre-Funded Warrants |
50K |
$250K |
$4.99 |
Jun 28, 2024 |
Indirect |
Common Stock |
|
Common Stock |
180K |
$1.8K |
$0.01 |
Nov 26, 2024 |
Direct |
|
|
Common Stock |
953 |
$9.53 |
$0.01 |
Nov 26, 2024 |
By Trust |
|
|
Common Warrants |
50K |
|
|
Jun 28, 2024 |
Direct |
Common Stock |
|
Common Warrants |
50K |
|
|
Jun 28, 2024 |
Indirect |
Common Stock |
|
Stock Option (Right to Buy) |
4.1K |
|
|
Nov 21, 2024 |
Direct |
Common Stock |
|
Warrant to Purchase Common Stock |
0 |
|
|
Nov 26, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.